|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8940 EUR | +0.68% |
|
-1.76% | -41.80% |
| 06-10 | AB Science presents new data on Masitinib |  |
| 05-17 | AB Science S.A. announced that it has received $2.989368 million in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AB SCIENCE | Specialty & Advanced Pharmaceuticals | +0.68% | -1.76% | -41.80% | -24.37% | -87.58% | 78.32M |  | | |
- Stock Market
- Stocks
- AB Stock
- Charts AB Science
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
